Clinical Trial Update: Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating a tenofovir-containing regimen for preventing mother-to-child transmission of HIV and hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV, Hepatitis B | Phase 2 | Status: COMPLETED